Home Your basket
• Pneumatization (concha bu...
   Price 8.50 €
• Singular neurectomy for r...
   Price 12.00 €
• New indications for heari...
   Price 8.50 €
• Voice after supracricoid ...
   Price 10.50 €
• Supra and infra hyoid mid...
   Price 10.50 €
• Papillary thyroid carcino...
   Price 10.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• The place of the myocutan...
   Price 10.50 €
• Sacrifice was an art: The...
   Price 8.50 €
• Post-traumatic otoscleros...
   Price 8.50 €
• Cat scratch disease: A di...
   Price 8.50 €
• Myringoplasties for anter...
   Price 10.50 €
• ENT localisation of amylo...
   Price 15.00 €
• Vocal rehabilitation with...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Is coincidence detection ...
   Price 10.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Endoscopic medialization ...
   Price 8.50 €
• Feasibility study of sept...
   Price 10.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• Outcome of surgical and a...
   Price 10.50 €
• Migrant foreign body of t...
   Price 10.50 €
• From the physiologic perf...
   Price 14.00 €
• Papillary thyroid microca...
   Price 10.50 €
• Dysphonia and cervical hy...
   Price 5.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Interest of hypnotherapy ...
   Price 10.50 €
• Management of swallowing ...
   Price 8.50 €
• Late metastasis from rena...
   Price 8.50 €
• Forcing the voice : the c...
   Price 5.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Otolaryngological aspects...
   Price 8.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Going from the tube feedi...
   Price 8.50 €
• Revascularized free scapu...
   Price 10.50 €
• Diagnosis of submandibula...
   Price 10.50 €
• Temporal lift...
   Price 10.50 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• Hearing evaluation on you...
   Price 8.50 €
• Myasthenia gravis and oro...
   Price 5.50 €
• Cervical approach to a li...
   Price 8.00 €
• Treatment and rehabilitat...
   Price 10.50 €
• The outcome of treatments...
   Price 10.50 €
• Alternative clinical mana...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Cholesteatoma behind a no...
   Price 10.50 €
• Rehabilitation strategies...
   Price 10.50 €
• Effect of vestibular neur...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• Occult otologic fistulas ...
   Price 5.50 €
• Temporomandibular dysfunc...
   Price 10.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• Comparison of radical (na...
   Price 10.50 €
• Augmentation of the abdom...
   Price 10.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Interests of multimedia s...
   Price 10.50 €
• Solitary fibrous tumour o...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Contribution of endoscopi...
   Price 8.50 €
• The subjective visual ver...
   Price 10.50 €
• Vocalab: A new software f...
   Price 8.50 €
• Reconstruction after hemi...
   Price 14.00 €
• Management of a huge amel...
   Price 5.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Voice Handicap Index adap...
   Price 10.50 €

Total Order 670.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2005 o

OTOLOGY

Influence of the relapse and remission periods on hearing status in children with minimal change nephrotic syndrome


Authors : Y. A. Bayazit, A. Balat, H. I. Pakir, E. Güler, M. Kanlikama (Ankara - Gaziantep)

Ref. : Rev Laryngol Otol Rhinol. 2005;126,3:171-173.

Article published in english
Downloadable PDF document english



Summary : Objective: Minimal change nephrotic syndrome (MCNS) is characterized by the onset of NS (Nephrotic Syndrome) without systemic disease, hypocomplementemia, or other serious signs of renal disease. Hearing status is not very well known in MCNS. Our objective was to address this question and to find out remission and relapse periods of the syndrome would affect the hearing of the patients. Methods and Patients: Otologic status of 26 children with clinical MCNS was investigated in relapse and remission periods using audiometry and tympanometry. The pure tones that were obtained at the frequencies 250, 500, 1000, 2000, 4000 and 6000 Hz were noted. Pure tone averages (PTAs) were calculated at 500, 1000, 2000 and 4000 Hz frequencies. Results: In both remission and relapse periods, PTA of the patients did not change and was 13 dB. The frequency specific pure tone results were not significantly different between the right and left ears of the patients as well as between the remission and relapse periods (p>0.05). In the relapsing and remission periods, type A tympanogram was encountered in 86.4% and 92.3% of the ears, respectively. Type B tympanogram was encountered in 11.5% and 3.8% of the ears in the relapsing and remission periods, respectively. Type C tympanogram was encountered in 3.8% of the ears both in the relapsing and remission periods. Differences between the tympanometry results were not significant (p>0.05). Conclusion: MCNS in childhood is not associated with an alteration in the hearing status, both in remission and relapse periods of the disease.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE